|
C2ORF76 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.819900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.097910E-02 |
| Normal-vs-Stage2 |
3.426000E-01 |
| Normal-vs-Stage3 |
5.272600E-01 |
| Normal-vs-Stage4 |
3.208000E-01 |
| Stage1-vs-Stage2 |
2.720600E-01 |
| Stage1-vs-Stage3 |
3.160800E-01 |
| Stage1-vs-Stage4 |
6.138600E-01 |
| Stage2-vs-Stage3 |
8.917800E-01 |
| Stage2-vs-Stage4 |
7.697400E-01 |
| Stage3-vs-Stage4 |
7.744200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.110300E-02 |
| Normal-vs-AfricanAmerican |
3.638000E-01 |
| Normal-vs-Asian |
6.610800E-01 |
| Caucasian-vs-AfricanAmerican |
1.504050E-01 |
| Caucasian-vs-Asian |
3.317800E-01 |
| AfricanAmerican-vs-Asian |
2.759000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.126490E-02 |
| Normal-vs-Female |
4.292000E-01 |
| Male-vs-Female |
3.222100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.263800E-01 |
| Normal-vs-Extreme_Weight |
2.598500E-02 |
| Normal-vs-Obese |
8.441900E-02 |
| Normal-vs-Extreme_Obese |
9.255200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.695390E-01 |
| Normal_Weight-vs-Obese |
4.099600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.702000E-01 |
| Extreme_Weight-vs-Obese |
5.424200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.878370E-01 |
| Obese-vs-Extreme_Obese |
3.097400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.593600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.225620E-01 |
| Normal-vs-Age(61-80Yrs) |
2.901600E-02 |
| Normal-vs-Age(81-100Yrs) |
1.606230E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.622200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.895800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.540000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.125800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.352800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.346000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.700200E-02 |
| Normal-VS-Type2 PRCC |
1.362230E-01 |
| Normal-VS-KIRP CIMP |
4.995800E-02 |
| Normal-VS-Unclassified PRCC |
8.234200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.400600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.561800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.452600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.641800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.509600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.096400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.305500E-02 |
| Normal-vs-N1 |
5.259600E-01 |
| Normal-vs-N2 |
8.635600E-01 |
| N0-vs-N1 |
2.618400E-01 |
| N0-vs-N2 |
4.264600E-01 |
| N1-vs-N2 |
8.853400E-01 |
|
|
